Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
Paraoxonase polymorphism MET-L...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients
Manylion Llyfryddiaeth
Prif Awduron:
Groves, C
,
Horton, V
,
Ritchie, A
,
Owen, R
,
Stratton, I
,
Green, F
,
Holman, R
,
Turner, R
Fformat:
Journal article
Cyhoeddwyd:
1998
Daliadau
Disgrifiad
Eitemau Tebyg
Dangos Staff
Eitemau Tebyg
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
gan: Stevens, R, et al.
Cyhoeddwyd: (2004)
Silent myocardial infarction is an independent risk factor for fatal myocardial infarction in patients with Type 2 diabetes
gan: Cull, C, et al.
Cyhoeddwyd: (2007)
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations
gan: Ilia Leviev, et al.
Cyhoeddwyd: (2001-04-01)
Serum myeloperoxidase, paraoxonase, and plasma asprosin concentrations in patients with acute myocardial infarction
gan: Handan Ciftci, et al.
Cyhoeddwyd: (2024-04-01)
UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
gan: Keavney, B, et al.
Cyhoeddwyd: (1995)